Table: begin end state 1 21 cytoplasmic 22 50 transmembrane 51 62 non-cytoplasmic 63 85 transmembrane 86 96 cytoplasmic 97 117 transmembrane 118 122 non-cytoplasmic 123 144 transmembrane 145 164 cytoplasmic 165 184 transmembrane 185 195 non-cytoplasmic 196 215 transmembrane 216 244 cytoplasmic 245 265 transmembrane 266 281 non-cytoplasmic 282 302 transmembrane 303 313 cytoplasmic 314 334 transmembrane 335 339 non-cytoplasmic 340 362 transmembrane 363 373 cytoplasmic 374 395 transmembrane 396 406 non-cytoplasmic 407 425 transmembrane 426 436 cytoplasmic
Input: >RR42_RS33875 FitnessBrowser__Cup4G11:RR42_RS33875 MTDSPRPAPLQPPSPEDIRKRIYAIVAASSGNLVEWFDFYVYAFCAIYFAPSFFPKADPT AQLLNTAGVFAAGFLMRPIGGWLFGRIADRHGRKTSMLISVLMMCFGSLLIACLPTYGAI GNWAPALLLLARLLQGLSVGGEYGTTATYMSEIALKGRRGFFSSFQYVTLIGGQLLAVLV VVVLQQLLDEGQLRSWGWRVPFVIGALTAVVALALRRTLRETSSAATRRNKEAGSLTALF RHHKAAFLTVLGYTAGGSLIFYTFTTYMQKYLVNSAGMSIKTASTVMTGCLFVYMCMQPL FGALSDRIGRRSNMLAFGALGTAATVPLLSALQIVSSPLAAFALISIALAIVSLYTSISG IVKAEMFPPEVRALGVGLAYAISNAIFGGSAEYVALALKSAGHQSAFYWYVTAMMALAFG VSLRLPRQARHLRHEY
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server